These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2934788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK.
    Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
    Scully BE, Henry SA.
    Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
    [Abstract] [Full Text] [Related]

  • 5. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ, Lee TJ.
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [Abstract] [Full Text] [Related]

  • 6. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F, Douchamps J, Freschi E, Thys JP, Nève P, Herchuelz A.
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [Abstract] [Full Text] [Related]

  • 7. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE, Neu HC.
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [Abstract] [Full Text] [Related]

  • 8. Clinical studies of aztreonam in Japan.
    Hara K, Kobayashi H, Nishiura T, Yura J, Saito A.
    Rev Infect Dis; 1985 Feb; 7 Suppl 4():S810-24. PubMed ID: 3909341
    [Abstract] [Full Text] [Related]

  • 9. Aztreonam: the first monobactam.
    Neu HC.
    Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
    [Abstract] [Full Text] [Related]

  • 10. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR, Chartrand SA, Tolentino T, Friedhoff L, Marks MI.
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA, Bendush CB.
    Am J Med; 1985 Feb 08; 78(2A):57-64. PubMed ID: 3881950
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP.
    Rev Infect Dis; 1985 Feb 08; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E, Bosch-Perez A.
    Chemotherapy; 1989 Feb 08; 35 Suppl 1():1-7. PubMed ID: 2659288
    [Abstract] [Full Text] [Related]

  • 19. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN, Heel RC.
    Drugs; 1986 Feb 08; 31(2):96-130. PubMed ID: 3512234
    [Abstract] [Full Text] [Related]

  • 20. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A, Thomaidou L, Loupa H, Papoulias G.
    Chemotherapy; 1989 Feb 08; 35 Suppl 1():101-5. PubMed ID: 2731446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.